Promising New Cancer Drugs Pose Other Health Threats

New and very promising cancer drugs are being tested, but there is a catch – the new drugs pose other health threats and the drugs may not pass FDA approval.
The new cancer-fighting drugs contain powerful drugs that give cancer cells a one-two punch and remove it from the body. The drugs contain CAR T, chimeric antigen receptor T cells, plus a powerful antibiotic known as bispecifics. The two work in tandem to grasp cancer cells from within the body, hold onto them and administer a lethal dose of antibiotics to the cells and/or tumor. The CAR T increases the potency of the antibiotics, enabling them to literally melt away cancerous tumors and eliminate them from the body. These new cancer drugs have been able to melt away tumors from cancer patients that have already been though chemotherapy and other conventional cancer treatments without success.
The downside of cancer treatment using the CAR T drugs is the cost of close to half a million dollars per patient and the threat the drugs pose to other aspects of health. The new cancer drugs and the disintegrated tumor cells release inflammatory chemicals, called cytokines, into the bloodstream during treatment. These residual cytokines can cause fever, a change in blood pressure and rapid heartbeat. The cytokines can be life-threatening to a cancer patient who is already in a compromised state of health. People like Brian Torchin are encouraged by these new findings. More on Torchin is available on DigitalJournal.com.